---
title: "Sera Prognostics announces proposed public offering"
date: "2025-02-11 00:23:31"
summary: "Sera Prognostics (NASDAQ:SERA) on Monday commenced a proposed underwritten public offering of its Class A common stock and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase shares of its Class A common stock. Sera intends to grant the underwriters a 30-day option to purchase..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Sera Prognostics (NASDAQ:[SERA](https://seekingalpha.com/symbol/SERA "Sera Prognostics, Inc.")) on Monday commenced a proposed underwritten public offering of its Class A common stock and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase shares of its Class A common stock.
* Sera intends to grant the underwriters a 30-day option to purchase shares of Class A common stock in an amount up to an additional 15% of the total amount of shares of Class A common stock and shares of Class A common stock underlying pre-funded warrants sold in the public offering on the same terms and conditions.
* Sera intends to use the net proceeds from the proposed offering to expand its commercial infrastructure and capabilities in the United States, accelerate preparations for expansion in the European Union, fund additional studies designed to increase adoption of the PreTRM test, including a potential submission to the U.S. Food and Drug Administration seeking broad approval of the PreTRM test, and for general corporate purposes.
* Source: [Press Release](https://seekingalpha.com/pr/19997232-sera-prognostics-announces-proposed-public-offering)

[seekalpha](https://seekingalpha.com/news/4405801-sera-prognostics-announces-proposed-public-offering)
